← Open Payments lookup

ALEXANDRIA KOUKOS: Open Payments

NPI 1205608619 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,310 in 154 payments from 30 companies in 2025. Trend: 2023 $400 · 2024 $3,509 · 2025 $3,310

Food & beverage: $3,310
CompanyPaymentsAmount
ABBVIE INC.29$581
AstraZeneca Pharmaceuticals LP12$251
Lilly USA, LLC14$244
Novo Nordisk Inc9$242
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$198
Axsome Therapeutics, Inc.12$188
Indivior Inc.7$185
Vanda Pharmaceuticals Inc.8$178
GlaxoSmithKline, LLC.9$163
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$159

Products named: VRAYLAR, CAPLYTA, SUBLOCADE, FANAPT, TRELEGY ELLIPTA, MOUNJARO, Wegovy, XIFAXAN.

Industry payments across CT — which companies pay providers there.